Association of biomarkers of inflammation, cartilage and bone turnover with gender, disease activity, radiological damage and sacroiliitis by magnetic resonance imaging in patients with early spondyloarthritis

被引:27
作者
Almodovar, Raquel [1 ]
Rios, Valeria [2 ]
Ocana, Sara [3 ]
Gobbo, Milena [4 ]
Casas, Maria-Luisa [3 ]
Zarco-Montejo, Pedro [1 ]
Juanola, Xavier [2 ]
机构
[1] Hosp Univ Fundac Alcorcon, Rheumatol Unit, Madrid 28922, Spain
[2] Hosp Univ Bellvitge, Dept Rheumatol, Barcelona, Spain
[3] Hosp Univ Fundac Alcorcon, Serv Clin Lab, Madrid, Spain
[4] SER, Res Unit, Madrid, Spain
关键词
Biomarkers; Cartilage; Extracellular matrix proteins; Magnetic resonance imaging; Spondyloarthritis; SOCIETY CLASSIFICATION CRITERIA; ANKYLOSING-SPONDYLITIS; MATRIX METALLOPROTEINASES; STRUCTURAL DAMAGE; SERUM-LEVELS; INHIBITORS; MATRIX-METALLOPROTEINASE-3; PROGRESSION; PREDICTOR; SYNOVITIS;
D O I
10.1007/s10067-013-2349-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To assess the association between biomarkers of inflammation, cartilage and bone turnover with gender, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Spondylitis Disease Activity Score (ASDAS) and bone marrow oedema in resonance magnetic imaging (MRI) of sacroiliac joints (SIJs) and radiological damage in early spondyloarthritis (SpA). Cross-sectional study of 60 patients (56.7 % females; mean age, 32.4 years) with early SpA. Sociodemographic data, clinical features, serum matrix metalloproteinase 3 (MMP-3), high sensitivity C-reactive protein (hsCRP), C-terminal cross-linking telopeptides of type I collagen (CTX-I) and urinary deoxypyridinoline, ASDAS, BASDAI, BASFI, BASRI and MRI of the SIJs were collected. The mean (SD) disease duration was 12.4 (6.8 months). Twenty-two (68.7 %) of the 32 patients had active sacroiliitis by MRI. MMP-3 and CTX I correlated with swollen joint (r = 0.515, r = 0.386, p = 0.01). hsCRP correlated with ESR (r = 0.303, p = 0.05), with CRP (r = 0.455, p = 0.01) and with total BASRI (r = 0.95, p = 0.05). Biomarkers were unrelated with the rest of variables. Levels of MMP-3 (44.3 +/- 52.4 vs 24.7 +/- 33.4, p < 0.05) and CTX-I (0.53 +/- 0.45 vs 0.24 +/- 0.38; p < 0.05) were higher in men. Our study shows that CTX-I and MMP-3 are a marker of peripheral disease activity in early SpA. Male gender had higher levels of CTX-I and MMP-3, which may indicate higher disease activity. Higher hsCRP levels trended towards correlation with more baseline radiographic damage. Therefore, these biomarkers may help identify a subgroup of patients who will need closer monitoring and more intensive treatment.
引用
收藏
页码:237 / 241
页数:5
相关论文
共 33 条
[1]   The effect of three years of TNF alpha blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study [J].
Arends, Suzanne ;
Spoorenberg, Anneke ;
Houtman, Pieternella M. ;
Leijsma, Martha K. ;
Bos, Reinhard ;
Kallenberg, Cees G. M. ;
Groen, Henk ;
Brouwer, Elisabeth ;
van der Veer, Eveline .
ARTHRITIS RESEARCH & THERAPY, 2012, 14 (02)
[2]   Serum MMP-3 Level as a Biomarker for Monitoring and Predicting Response to Etanercept Treatment in Ankylosing Spondylitis [J].
Arends, Suzanne ;
van der Veer, Eveline ;
Groen, Henk ;
Houtman, Pieternella M. ;
Jansen, Tim L. T. A. ;
Leijsma, Martha K. ;
Bijzet, Johan ;
Limburg, Pieter C. ;
Kallenberg, Cees G. M. ;
Spoorenberg, Anneke ;
Brouwer, Elisabeth .
JOURNAL OF RHEUMATOLOGY, 2011, 38 (08) :1644-1650
[3]  
CALIN A, 1994, J RHEUMATOL, V21, P2281
[4]   Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? [J].
Calin, A ;
Nakache, JP ;
Gueguen, A ;
Zeidler, H ;
Mielants, H ;
Dougados, M .
RHEUMATOLOGY, 1999, 38 (09) :878-882
[5]   Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity [J].
Chen, CH ;
Lin, KC ;
Yu, DTY ;
Yang, C ;
Huang, F ;
Chen, HA ;
Liang, TH ;
Liao, HT ;
Tsai, CY ;
Wei, JCC ;
Chou, CT .
RHEUMATOLOGY, 2006, 45 (04) :414-420
[6]   Soluble and Tissue Biomarkers in Ankylosing Spondylitis [J].
de Vlam, Kurt .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2010, 24 (05) :671-682
[7]   THE EUROPEAN-SPONDYLARTHROPATHY-STUDY-GROUP PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SPONDYLARTHROPATHY [J].
DOUGADOS, M ;
VANDERLINDEN, S ;
JUHLIN, R ;
HUITFELDT, B ;
AMOR, B ;
CALIN, A ;
CATS, A ;
DIJKMANS, B ;
OLIVIERI, I ;
PASERO, G ;
VEYS, E ;
ZEIDLER, H .
ARTHRITIS AND RHEUMATISM, 1991, 34 (10) :1218-1227
[8]   Diagnosing early spondyloarthritis in Spain: the ESPeranza program [J].
Fernandez Carballido, Cristina .
REUMATOLOGIA CLINICA, 2010, 6 :6-10
[9]  
Lange U, 2000, Eur J Med Res, V5, P507
[10]   Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis [J].
Lukas, C. ;
Landewe, R. ;
Sieper, J. ;
Dougados, M. ;
Davis, J. ;
Braun, J. ;
van der Linden, S. ;
van der Heijde, D. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (01) :18-24